Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Randomized Study of Albendazole in Patients With Epilepsy Due to Neurocysticercosis
This study is ongoing, but not recruiting participants.
Study NCT00004403.   Last updated on June 23, 2005.
Information provided by FDA Office of Orphan Products Development
Please refer to this study by its ClinicalTrials.gov identifier: NCT00004403
Sponsors and Collaborators
FDA Office of Orphan Products Development
Johns Hopkins University
Investigators
Study Chair: Robert H. Gilman Johns Hopkins University